Related Experiment Video
Updated: Jul 10, 2026

Application of Hemostatic Devices in Laparoscopic Hepatectomy
Published on: April 19, 2022
Management of hemostasis in vascular surgery
Brian R Untch1, Joseph W Turek, Roberto J Manson
1Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
Abstract:
The fate of the circulatory system in response to vascular injury is governed by a series of complex biochemical reactions involving cellular elements and plasma proteins. Alteration of this hemostatic balance can result in excessive bleeding or procoagulant complications. In the field of vascular surgery, modulation of this process can have severe implications with respect to the maintenance of vascular conduit patency by avoiding thromboembolic events and the prevention of excess bleeding in the operative setting. The nature of the hemostatic response in the setting of surgical-induced injury and stress is increasingly complex and not fully understood. When faced with the management of bleeding in the operative setting, the vascular surgeon must first understand the theories of hemostatic regulation before adapting these concepts to the surgical milieu. This review addresses the management of blood loss in the setting of vascular surgery. In so doing, insight will be shed on the interdependence and manipulation of hemostatic events as they relate to surgery. Topics related to preoperative evaluation, surgical technique, monitoring, and pharmacologic manipulation will be discussed.
Related Concept Videos
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Vascular Spasm
Anticoagulant Drugs: Low-Molecular-Weight Heparins

